Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion type Assertion NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_head.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion description "[In a case-control study, we investigated the genotype frequencies of 10 estrogen metabolizing SNPs in 32 patients with endometriosis and 790 healthy controls using sequencing-on-chip-technology with solid-phase polymerase chain reaction on oligonucleotide microarrays: catechol-O-methyltransferase, Val158Met G->A, 17-beta-hydroxysteroid dehydrogenase type 1 (HSD17), vlV A->C, cytochrome P450 (CYP), 17 A2 allele T->C, CYP1A1 MspI RFLP T->C, CYP1A1 Ile462Val A->G, CYP19 Arg264Cys C->T, CYP19 C1558T C->T, CYP 1B1 Leu432Val, CYP1B1 Asn453Ser, and estrogen receptor alpha IVS1 -401>C. Associations and 2-way interaction models between SNPs were calculated by stepwise logistic regression models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_provenance.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion evidence source_evidence_literature NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_provenance.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion SIO_000772 16260521 NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_provenance.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion wasDerivedFrom gad-20150221 NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_provenance.
- NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_assertion wasGeneratedBy ECO_0000203 NP96789.RAlUtinfRuxtwh4f_cCA8ID9w4-ctYM-BB6A5q5PGNrDs130_provenance.